Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bevan Moseley is active.

Publication


Featured researches published by Bevan Moseley.


EFSA Journal | 2010

Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre

Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen

This Opinion of the EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA) deals with the establishment of Dietary Reference Values for carbohydrates and dietary fibre. Nutritionally, two broad categories of carbohydrates can be differentiated: “glycaemic carbohydrates”, i.e. carbohydrates digested and absorbed in the human small intestine, and ‘dietary fibre’, non-digestible carbohydrates passing to the large intestine. In this Opinion, dietary fibre is defined as non-digestible carbohydrates plus lignin. The absolute dietary requirement for glycaemic carbohydrates is not precisely known but will depend on the amount of fat and protein ingested. The Panel proposes 45 to 60 E% as the reference Intake range for carbohydrates applicable to both adults and children older than one year of age. Although high frequency of intake of sugar-containing foods can increase the risk of dental caries, there are insufficient data to set an upper limit for (added) sugar intake. Based on the available evidence on bowel function, the Panel considers dietary fibre intakes of 25 g/day to be adequate for normal laxation in adults. A fibre intake of 2 g/MJ is considered adequate for normal laxation in children from the age of one year. Although there is some experimental evidence that a reduction of the dietary glycaemic index and glycaemic load may have favourable effects on some metabolic risk factors such as serum lipids, the evidence for a role in weight maintenance and prevention of diet-related diseases is inconclusive.


EFSA Journal | 2010

Scientific Opinion on lactose thresholds in lactose intolerance and galactosaemia

Panel on Dietetic Products Nutrition; E. Allergies; Carlo Agostoni; Jean-Louis Bresson; Susan J. Fairweather-Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; Monika Neuhäuser‐Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


Archive | 2008

Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Jean-Louis Bresson; Albert Flynn; Marina Heinonen; Karin Hulshof; Hannu Korhonen; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; Hildegard Przyrembel; Seppo Salminen; Stephan Strobel; Inge Tetens; Henk van den Berg; Hendrik van Loveren; Hans Verhagen


EFSA Journal | 2010

Scientific Opinion in relation to the authorisation procedure for health claims on calcium and vitamin D and the reduction of the risk of osteoporotic fractures by reducing bone loss pursuant to Article 14 of Regulation (EC) No 1924/2006

Efsa Panel on Dietetic Products Nutrition; Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


EFSA Journal | 2010

Scientific Opinion on the substantiation of health claims related to bonito protein peptide and maintenance of normal blood pressure (ID 1716) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Efsa Panel on Dietetic Products Nutrition; Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


EFSA Journal | 2010

Scientific Opinion on the safety of ‘Cetyl Myristoleate Complex’ as a food ingredient

Carlo Agostoni; Jean-Louis Bresson; Susan J. Fairweather-Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; Monika Neuhäuser‐Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


Archive | 2012

Scientific opinion on dietary reference values for protein : EFSA panel on dietetic products, nutrition and allergies (NDA)

Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


EFSA Journal | 2011

Scientific Opinion on the substantiation of health claims related to resistant maltodextrin and reduction of post-prandial glycaemic responses (ID 796), maintenance of normal blood LDL-cholesterol concentrations (ID 2927), maintenance of normal (fasting) blood concentrations of triglycerides (ID 2927) and changes in bowel function (ID 797) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


EFSA Journal | 2010

Scientific Opinion on the substantiation of health claims related to various food(s)/food constituents(s) and increasing numbers of gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905), and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Carlo Agostoni; Jean-Louis Bresson; Susan J. Fairweather-Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; Monika Neuhäuser‐Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen


Archive | 2012

Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) : EFSA panel on dietetic products, nutrition and allergies (NDA)

Carlo Agostoni; Jean-Louis Bresson; S. Fairweather Tait; Albert Flynn; I. Golly; Hannu Korhonen; Pagona Lagiou; Martinus Løvik; Rosangela Marchelli; Ambroise Martin; Bevan Moseley; M. Neuhäuser Berthold; Hildegard Przyrembel; Seppo Salminen; Yolanda Sanz; S. Strain; Stephan Strobel; Inge Tetens; Daniel Tomé; H. van Loveren; H. Verhagen

Collaboration


Dive into the Bevan Moseley's collaboration.

Top Co-Authors

Avatar

Albert Flynn

University College Cork

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Inge Tetens

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martinus Løvik

Norwegian Institute of Public Health

View shared research outputs
Top Co-Authors

Avatar

Carlo Agostoni

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Yolanda Sanz

Spanish National Research Council

View shared research outputs
Researchain Logo
Decentralizing Knowledge